ABSTRACT. Bovine serum contains N-acetyl-D-glucosamine (GlcNAc)-sensitive opsonin inhibitory factors. In the present study, a major component of chitin-binding protein (chitin-binding protein b01, CBPb01) was purified from bovine serum, and identified CBPb01 as bovine IgM by its subunit structure, antigenic properties, and partial sequences. The results of a lectin-binding assay showed that the heavy chain of CBPb01 had a GlcNAc structure, but the commercial IgM did not. It is possible that CBPb01 interconnects through its GlcNAc structure, subsequently forming complexes. We also demonstrated that CBPb01 had opsonin-inhibitory activity, and that this activity was dependent on the binding of CBPb01 to GlcNAc on the zymosan surface. These findings indicate the presence of a kind of IgM that recognizes GlcNAc structure in the regulation of opsonization. KEY WORDS: bovine serum, chitin, GlcNAc, IgM, opsonin-regulatory protein.
The immune response to microbial pathogens relies on both innate and adaptive components [8] . The immediate, innate response is mediated largely by white blood cells such as neutrophils and macrophages, cells that phagocytose and kill pathogens [1] . In cattle, neutrophils are principally responsible for maintaining the host's first line of defense against invading microorganisms [16] . The efficient recognition and binding of microorganisms by neutrophils reside in adaptive components-opsonins. The major opsonins in serum (complement factors C3b and C3bi, the IgG and IgM classes of immunoglobulin, and serum lectins) coat the surface of targets and attach to corresponding receptors on the neutrophil plasma membrane [6, 12] .
In a previous study, we investigated the opsonizing property of bovine serum for zymosan using neutrophil-stimulating activity. In brief, we found that neutrophil-stimulating activity was markedly enhanced when zymosan was opsonized in the presence of GlcNAc, but mannose, glucose, or fructose showed no enhancing effect. These results suggest that GlcNAc-sensitive opsonin regulatory proteins are present in bovine serum [18] . Nakao et al. reported that there were at least ten kinds of proteins that bound to chitin, a polymer of GlcNAc, in bovine serum, and that the major component of chitin-binding protein (called CBPb01) had a high molecular mass (1,800 kDa) and consisted of two subunits [13] . In this study, we identified CBPb01 as bovine IgM and revealed that CBPb01 regulates the opsonization of zymosan.
MATERIALS AND METHODS
Bovine serum: Bovine serum was prepared from the blood of healthy Holstein cows. The collected serum was stored at -20°C before use.
Purification of CBPb01: CBPb01 was purified as described previously [13] . Purified CBPb01 was stored at -20°C before use in the experiments.
Characterization of CBPb01: Purified CBPb01 (0.5 mg) in 100 mM Tris-HCl (pH 8.0), containing 5 mM 2-mercaptoethanol (2-ME), 6 M guanidine hydrochloride, 2 mM ethylenediaminetetracetic acid (EDTA), was incubated for 4 hr at 50°C in N 2 gas. After the incubation, 5 mM iodoacetamide was added to this mixture, which was incubated for a further 30 min [7] . The subunits of the purified CBPb01 were isolated by gel filtration with an HW-55s column equilibrated with 6 M urea-B-Nap (20 mM Na 2 B 4 O 2 ·10H 2 O, 60 mM NaH 2 PO 4 ·2 H 2 O; pH 8.1). The 85-kDa subunit was digested with lysyl endpeptidase (from Achromobacter lyticus M497-1; Wako, Osaka, Japan) in 100 mM Tris-HCl (pH 9.0), with incubation for 6 hr at 37°C. After digestion, the resultant peptides were analyzed using matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) (PerSeptive Biosystems, Inc., Framingham, MA, U.S.A.) [20] and then purified by reverse phase chromatography using a column of TSK gel ODS-80TsQA (TOSOH, Tokyo, Japan). The purified peptides were analyzed by automated Edman degradation using a PPSQ-21 protein sequencer (Shimadzu, Tokyo, Japan) [5] . The sequences obtained were compared with those in the DDBJ.
Double immunodiffusion test with goat anti-bovine IgM antibody:
A double immunodiffusion test was performed using goat anti-bovine IgM antibody (ICN Pharmaceuticals, Inc. CA, U.S.A.) as described previously [15] . A commercial bovine IgM (CHEMICON International, Inc., Ohio, U.S.A.) was used as a control.
Lectin-binding assay: The purified CBPb01 and the commercial IgM were subjected to SDS-PAGE in the presence of 2-ME [11] , and proteins were blotted onto a polyvinylidene difluoride (PVDF) membrane [19] . Then, the blot was incubated in blocking buffer (3% BSA) for 1 hr. Each blot strip was incubated for 1 hr in PBS containing one of the following biotinylated lectins (biotinylated lectin kit, FUNAKOSHI, Tokyo, Japan): Con A (Concanavalin A), WGA (Wheat germ agglutinin), DBA (Dolichos biflorus agglutinin), UEA-1 (Ulex europaeus agglutinin-1), PNA (Peanut agglutinin) or SBA (Soybean agglutinin). The blots were further incubated in avidin-biotin-HRP complex solution (VECTASTAIN ABC kit, FUNAKOSHI) for 1 hr, and then incubated in the staining buffer (0.8 mM DAB, 0.01 mM H 2 O 2 ) [3] . Staining intensity was classified into four levels: negative, no signal was observed; slight, a weak signal was observed; moderate, a moderate signal was observed; and strong, a strong signal was observed.
Polymorphonuclear cell (PMN) isolation: Blood samples were collected from the jugular vein of healthy Holstein cows. Heparin sulfate was used as an anticoagulant. A granulocyte-enriched preparation was obtained using a previously reported method [10] . Total cell counts were determined microscopically using Trypan blue exclusion. The separated cells were resuspended to a concentration of 3 × 10 7 cells/ml in HBSS(-), and allowed to stand at 0°C before use.
Opsonization and CBPb01 treatment of zymosan: Zymosan (Sigma Chemical Co., St. Louis, MO, U.S.A.) (10 mg) was opsonized by incubation with 1 ml of bovine serum at 37°C for 30 min before and after incubation with 1 ml of CBPb01 (0.1 mg/ml in PBS), followed by three washes with one 1 ml of HBSS(-) each. All zymosan preparations were resuspended in a final concentration of 10 mg/ml in HBSS (-).
Chemiluminescence assay of neutrophil-stimulating activity: Opsonin activity was measured as the intensity of chemiluminescence when the neutrophils were stimulated with the zymosan preparations [23] . Luminescence generated was continuously determined using a luminometer (LKB, Uppsala, Sweden) at 37°C.
RESULTS

Characterization of the purified CBPb01:
To further characterize the purified CBPb01, the 85-kDa subunit was digested by lysyl endpeptidase and the resultant digest was analyzed for the presence of peptides by MALDI-TOF. The results were compared with those in the MS-Fit 3.1.1 database (held at the University of California). Comparison analysis indicated that CBPb01 was the bovine IgM heavy chain. In addition, the amino acid sequence of the derived peptides was analyzed after purification using reverse phase chromatography. The sequences were compared with those in the DDBJ, and were verified as bovine IgM heavy chain (Fig. 1A) .
The double immunodiffusion test of CBPb01 with goat anti-bovine IgM whole molecule antibody showed the appearance of a precipitin line between CBPb01 and the antibody. These results also indicated that CBPb01 was bovine IgM (Fig. 1B) .
Lectin-binding assay: The lectin binding properties of CBPb01 and commercial IgM were tested using Western blot analysis with biotinylated lectins. A significant difference between the heavy chain of CBPb01 and commercial IgM was found in the WGA binding property. CBPb01 had a GlcNAc moiety, but commercial IgM did not (Table 1) . 
A
The effect of CBPb01 on the neutrophil-stimulating activity of opsonized zymosan: First, it was confirmed that CBPb01 could bind to zymosan using sodium dodecyl sulfate -polyacrylamide gel electrophoresis (SDS-PAGE) and silver staining. In brief, 2 mg of zymosan were incubated in 200 µl of CBPb01 solution (containing either 5, 10, 25, or 50 µg/ml CBPb01 concentration) at 37°C for 30 min. The zymosan preparations were washed three times with HBSS(-) and then analyzed by SDS-PAGE. Binding of CBPb01 to zymosan was confirmed at CBPb01 concentrations from 10 to 50 µg/ml (data not shown).
To investigate the effect of CBPb01 on the opsonization of zymosan, bovine neutrophils were stimulated by five kinds of zymosan preparations: zymosan was opsonized with bovine serum (OZ), zymosan was opsonized with bovine serum after CBPb01 treatment (pre-OZ), zymosan was treated with CBPb01 after opsonization (post-OZ), and zymosan was incubated with CBPb01 (CZ) or HBSS(-) (HZ). When bovine neutrophils were stimulated by pre-OZ or post-OZ, chemiluminescence emissions were significantly lower than with the OZ control (p<0.001) (Fig. 2) . To reveal whether this inhibition depends on the binding of CBPb01 to a GlcNAc structure on the zymosan surface, zymosan was pre-treated with CBPb01 in the presence or absence of 0.1 M GlcNAc. When neutrophils were stimulated by pre-OZ prepared in the presence of GlcNAc, the neutrophil-stimulating activity had recovered to the level of OZ control (Fig. 3) .
DISCUSSION
Nakao et al. reported that the main component of chitinbinding protein in bovine serum, CBPb01, is a high-molecular-size protein of about 1,800 kDa (determined using gel filtration) that consists of two subunits with molecular masses of 85 and 30 kDa (determined by SDS-PAGE under the reducing condition) [13] . In this study, we identified CBPb01 as bovine IgM using the double immunodiffusion test and amino acid sequencing. Since the molecular mass of IgM is reported to be 900 kDa [14] , CBPb01 might be a dimer form of IgM molecules. The lectin-binding assay showed that WGA, a GlcNAc-specific lectin, binds to CBPb01, but not to commercial IgM. This indicates that CBPb01 has a GlcNAc structure. Thus, it is possible that CBPb01 interconnects through its GlcNAc structure, subsequently forming complexes. Nakao et al. measured the molecular mass of CBPb01 by gel filtration with a column of HW-65S, and CBPb01 was eluted at a position corresponding to 1,800 kDa, suggesting that the CBPb01 mole- 
-, ±, +, ++ staining intensity: negative, slight, moderate, and strong, respectively. Fig. 2 . The effect of CBPb01 on the neutrophil-stimulating activity of opsonized zymosan. Opsonin activity was measured as the intensity of luminol-dependent chemiluminescence when the neutrophils were stimulated with the zymosan preparations. Four zymosan preparations were prepared as previously described. The chemiluminescence emissions of bovine neutrophils were measured using a luminometer. OZ, opsonized with bovine serum; pre-OZ, opsonized with bovine serum after CBPb01 treatment; post-OZ, treated with CBPb01 after opsonization; CZ, incubated with CBPb01; HZ, incubated with HBSS(-). * Significantly different compared to OZ (p<0.001). cule forms a dimer via the GlcNAc moiety.
In our previous study, we demonstrated that bovine serum has GlcNAc-sensitive, opsonin-regulatory proteins [18] . Thus, we investigated whether CBPb01 has opsonin-regulatory activity. Pre-or post-treatment with CBPb01 decreased the neutrophil-stimulating activity of opsonized zymosan. Furthermore, when treated in the presence of 0.1 M GlcNAc, the neutrophil-stimulating activity recovered to the level of the opsonized zymosan control. These results suggest that CBPb01 is a GlcNAc-sensitive opsonin inhibitory factor. In our preliminary study, we observed that pretreatment with the commercial IgM also decreased the activity (30%), although the decrease was less than that with CBPb01 (44.6%). It is possible that the commercial material contained zymosan-binding IgM and partially exhibited CBP-b01-like activity.
Neutrophils possess carbohydrate-binding membrane structures that mediate the recognition and ingestion of sugar-coated beads [22] , and GlcNAc coating enhances the recognition and phagocytosis of the beads by neutrophils [4] . Since the opsonin-regulatory activity of CBPb01 is canceled by the presence of GlcNAc, CBPb01 might be regulated via CBP01 masking the GlcNAc on the surface of zymosan.
Although this study found that CBPb01, the GlcNAcbinding IgM, has an inhibitory effect on opsonization, there are several reports that IgM enhances the effect or has no apparent effect. Guidry et al. [6] reported the opsonization of Staphylococcus aureus by IgM isolated from immunized serum. Bjornson and Detmers [2] reported that natural human IgM enhanced the opsonization of Bacteroides via the alternative complement pathway. In contrast, Howard [9] reported that purified bovine IgM showed no effect on killing a microorganism, Mycoplasma bovis, by neutrophils. The reason for the discrepancies in these studies, including ours, is not clear at present, but might be due to differences in the methods used in each study. Neutrophils have membrane receptors for complement, such as CR3, but no Fc receptor for IgM, Fc µ R [17, 21] . Since Worku et al. [24] reported the direct binding of fluorescein-labeled IgM to the surface of neutrophils, other unidentified membrane receptors might be present and contribute to the reaction.
In conclusion, our results suggest a new role for IgMthe recognition of GlcNAc and the inhibition of opsonization. The combination of this inhibitory effect and the previously reported activating effect may account for the total opsonization activity of IgM on neutrophils.
